228 related articles for article (PubMed ID: 20937296)
21. Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).
Nyland RL; Luo M; Kelley MR; Borch RF
J Med Chem; 2010 Feb; 53(3):1200-10. PubMed ID: 20067291
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1.
Kelley MR; Luo M; Reed A; Su D; Delaplane S; Borch RF; Nyland RL; Gross ML; Georgiadis MM
Antioxid Redox Signal; 2011 Apr; 14(8):1387-401. PubMed ID: 20874257
[TBL] [Abstract][Full Text] [Related]
23. Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain.
Jung SB; Kim CS; Kim YR; Naqvi A; Yamamori T; Kumar S; Kumar A; Irani K
PLoS One; 2013; 8(6):e65415. PubMed ID: 23755229
[TBL] [Abstract][Full Text] [Related]
24. Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function.
Vascotto C; Bisetto E; Li M; Zeef LA; D'Ambrosio C; Domenis R; Comelli M; Delneri D; Scaloni A; Altieri F; Mavelli I; Quadrifoglio F; Kelley MR; Tell G
Mol Biol Cell; 2011 Oct; 22(20):3887-901. PubMed ID: 21865600
[TBL] [Abstract][Full Text] [Related]
25. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
[No Abstract] [Full Text] [Related]
26. Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines.
Cesaratto L; Codarin E; Vascotto C; Leonardi A; Kelley MR; Tiribelli C; Tell G
PLoS One; 2013; 8(8):e70909. PubMed ID: 23967134
[TBL] [Abstract][Full Text] [Related]
27. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
Ding J; Fishel ML; Reed AM; McAdams E; Czader MB; Cardoso AA; Kelley MR
Mol Cancer Ther; 2017 Jul; 16(7):1401-1411. PubMed ID: 28446640
[TBL] [Abstract][Full Text] [Related]
28. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
30. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
31. NMR studies reveal an unexpected binding site for a redox inhibitor of AP endonuclease 1.
Manvilla BA; Wauchope O; Seley-Radtke KL; Drohat AC
Biochemistry; 2011 Dec; 50(48):10540-9. PubMed ID: 22032234
[TBL] [Abstract][Full Text] [Related]
32. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
34. Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro.
Rohrabaugh SL; Hangoc G; Kelley MR; Broxmeyer HE
Exp Hematol; 2011 Apr; 39(4):415-23. PubMed ID: 21216274
[TBL] [Abstract][Full Text] [Related]
35. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
[TBL] [Abstract][Full Text] [Related]
36. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
[TBL] [Abstract][Full Text] [Related]
37. APE1/Ref-1 Inhibits Phosphate-Induced Calcification and Osteoblastic Phenotype Changes in Vascular Smooth Muscle Cells.
Lee KM; Lee EO; Lee YR; Joo HK; Park MS; Kim CS; Choi S; Jeong JO; Jeon BH
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946662
[TBL] [Abstract][Full Text] [Related]
38. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
[TBL] [Abstract][Full Text] [Related]
39. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
